The number of people with susceptibility test result for rifampicin in Peru
Peru: The number of people with susceptibility test result for rifampicin was 13,453 in 2021. ▼ Falling
Latest (2021)
13,453
Change on year
up 40.4%
World rank
18th
of 155 countries
All-time high
14,261
in 2017
All-time low
9,583
in 2020
Years of data
5
2017–2021
The number of people with susceptibility test result for rifampicin in Peru, 2017–2021
Source: World Health Organization, Global Health Observatory.
Analysis
Peru recorded 13,453 for the number of people with susceptibility test result for rifampicin in 2021.
The figure is up 40.4% on the previous year and down 5.7% over five years.
Peru ranks 18th of 155 countries on this measure, in the top quarter.
The number of people with susceptibility test result for rifampicin in Peru, year by year
| Year | Value | Change |
|---|---|---|
| 2017 | 14,261 | — |
| 2018 | 12,771 | -10.4% |
| 2019 | 13,424 | +5.1% |
| 2020 | 9,583 | -28.6% |
| 2021 | 13,453 | +40.4% |
Peru compared with similar countries
- Peru's 13,453 is above the median for upper middle income countries, which is 880, 15.3× the median. (46 countries reporting)
- Peru's 13,453 is above the median for Latin America & Caribbean, which is 406.5, 33.1× the median. (26 countries reporting)
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2010s | 13,485 | 12,771 | 14,261 | 3 |
| 2020s | 11,518 | 9,583 | 13,453 | 2 |
Countries ranked near Peru
More health data for Peru
- Un projection of annual infant deaths, annual growth rate -1.88 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate 0.5045 % change on previous year (2090)
- Estimated changes in temperature-related death rates compared to projected death rates 1,235 deaths per 1,000 people (2090)
- Number of infants who die before age 1 782 deaths (2100)
- Neonatal tetanus - number of reported cases, gaps filled 2 (2025)
- Population ages 00-04, female, annual growth rate -0.3081 % change on previous year (2025)
- Population ages 00-04, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 00-04, female, per capita 0.038 units per person (2025)
- Population ages 00-04, male, annual growth rate -0.302 % change on previous year (2025)
- Population ages 00-04, male, per unit of GDP 0 units per US$ of GDP (2025)
Frequently asked questions
- What is the number of people with susceptibility test result for rifampicin in Peru?
- The number of people with susceptibility test result for rifampicin in Peru was 13,453 in 2021, according to World Health Organization, Global Health Observatory.
- What is the highest the number of people with susceptibility test result for rifampicin recorded in Peru?
- The highest recorded value was 14,261 in 2017.
- What is the lowest the number of people with susceptibility test result for rifampicin recorded in Peru?
- The lowest recorded value was 9,583 in 2020.
- How does Peru rank for the number of people with susceptibility test result for rifampicin?
- Peru ranks 18th out of 155 countries with data for 2021.
- Where does this Peru data come from?
- The figures come from World Health Organization, Global Health Observatory, published as part of The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.. Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 5 observations, free to reuse under CC BY-NC-SA 3.0 IGO (WHO).